Allergan reports positive Phase IIb two-year data from liver fibrosis trial

Allergan has reported positive top-line two-year results from its Phase IIb CENTAUR clinical trial of Cenicriviroc (CVC) to treat liver fibrosis in adults suffering from non-alcoholic steatohepatitis (NASH).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news